| 2011 | Prognostic factors of second and third line chemotherapy using 5-fu with platinum, irinotecan, and taxane for advanced gastric cancer.
| CANCER RESEARCH AND TREATMENT |
| 2011 | Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats.
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2011 | Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer.
| PLOS ONE |
| 2011 | Gene expression signature-based prognostic risk score in gastric cancer
| CLINICAL CANCER RESEARCH |
| 2010 | Outcome of adjuvant therapy for gallbladder cancer | ONCOLOGY |
| 2009 | Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2009 | Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study Group
| JOURNAL OF THORACIC ONCOLOGY |
| 2009 | Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma. | CHEMOTHERAPY |
| 2008 | Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma. | ANTI-CANCER DRUGS |
| 2008 | Salvage chemotherapy with docetaxel and epirubicin for Advanced/Metastatic gastric cancer | ONCOLOGY |
| 2008 | A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2007 | Docetaxel-Induced Onycholysis: The Role of Subungual Hemorrhage and Suppuration
| YONSEI MEDICAL JOURNAL |
| 2007 | Non-Hodgkin's lymphoma of the sphenoid sinus presenting as isolated oculomotro never palsy
| WORLD JOURNAL OF SURGICAL ONCOLOGY |
| 2007 | Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS |
| 2006 | Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer | ONCOLOGY REPORTS |
| 2006 | 임신 중 발견된 뇌전이를 동반한 유방의 원발성악성림프종 1예
| Korean Journal of Hematology |
| 2006 | 9-cis retinoic acid induces insulin-like growth factor binding protein-3 through DR-8 retinoic acid responsive elements
| CANCER BIOLOGY & THERAPY |
| 2006 | Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma | JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY |
| 2005 | Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma
| CANCER |
| 2005 | 간세포암 환자에서 간동맥 화학색전술 후 발생한 급성 간부전의 위험인자
| Korean Journal of Medicine (대한내과학회지) |
| 2005 | A Phase II Study of Capecitabine Combined with Gemcitabine in Patients with Advanced Gallbladder Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2004 | A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
| ANNALS OF ONCOLOGY |
| 2003 | Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer
| CANCER RESEARCH AND TREATMENT |
| 2002 | Evaluation of E1b gene-attenuated replicating adenoviruses for cancer gene therapy
| CANCER GENE THERAPY |
| 2002 | Observation of Cabibbo-suppressed and W-exchange Λc+ baryon decays | PHYSICS LETTERS B |
| 1999 | 노령층 비호지킨 림프종 환자의 치료성적 및 예후
| Journal of the Korean Cancer Association (대한암학회지) |
| 1999 | Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector | ONCOLOGY REPORTS |
| 1997 | 생물학적 치료 목표로서 위암에서 Midkine 발현의 탐색 | Journal of the Korean Cancer Association (대한암학회지) |
| 1997 | Relationship between p53 Overexpression and Gastric Cancer Progression | ONCOLOGY |
| 1997 | High Level of Urokinase-Type Plasminogen Activator Is a New Prognostic Marker in Patients with Gastric Carcinoma | CANCER |
| 1997 | Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma | CANCER |
| 1997 | Retrospective Comparison of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Modified FAM) Combination Chemotherapy Versus Palliative Therapy in Treatment of Advanced Gastric Cancer | American Journal of Clinical Oncology |
| 1996 | 악성 종양 환자에서 새로운 Anthracycline 유도체: DA-125의 제1상 및 약동학 연구
| Journal of the Korean Cancer Association(대한암학회지) |
| 1996 | 골육종환자에서 다방면 복합요법의 효과 및 P-Glycoprotein 과다발현의 임상적 의의
| Journal of the Korean Cancer Association(대한암학회지) |
| 1996 | Overexpression of c-ErbB-2 Protein in Gastric Cancer by Immunohistochemical Stain | ONCOLOGY |
| 1996 | 위암에서 침윤과 전이의 새로운 생물학적 표지자로서 urokinase-type plasminogen activator(uPA)의 발현
| Journal of the Korean Cancer Association(대한암학회지) |
| 1996 | 직장암에서 c-erbB-3의 발현과 예후인자로서 임상적 응용
| Journal of the Korean Cancer Association(대한암학회지) |
| 1995 | 인체 위암조직에서 새로운 생물학적 치료목표로서 기저막 단백분해효소(Matrix-metalloproteinase-2,-9)의 발현
| Journal of the Korean Cancer Association(대한암학회지) |
| 1995 | 근치적 절제술이 시행된 대장 및 직장암에서 c-erbB-2의 표현과 임상적 의의
| Journal of the Korean Cancer Association(대한암학회지) |
| 1995 | 임파절 전이가 없는 유방암의 예후인자
| Journal of the Korean Cancer Association(대한암학회지) |
| 1995 | 위암환자의 종양지표지자로서 혈액내 c-erbB-2 종양단백의 탐색
| Journal of the Korean Cancer Association(대한암학회지) |
| 1995 | 진행위암환자에서 지속주입 5-Fluorouracil,Doxorubicin,Mitomycin-C(Modified FAM) 병용요법과 보조요법의 후향적 비교연구
| Journal of the Korean Cancer Association(대한암학회지) |
| 1995 | 항암화학요법에 의하여 골수억제가 수반된 진행암 환자에서 Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor(rhGM-CSF,LBD-005)의 제3상 임상연구;rhGM-CSF의 백혈구 감소증에 대한 효과
| Journal of the Korean Cancer Association(대한암학회지) |
http://orcid.org/0000-0002-0926-1819
(36805119200)
